Welcome to LookChem.com Sign In|Join Free

CAS

  • or

110548-07-7

Post Buying Request

110548-07-7 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

110548-07-7 Usage

Uses

The R-enantiomer of Levofloxacin Carboxylic Acid (L360250); an impurity of Levofloxacin. The (S)-enantiomer is substantially the more active.

Check Digit Verification of cas no

The CAS Registry Mumber 110548-07-7 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,1,0,5,4 and 8 respectively; the second part has 2 digits, 0 and 7 respectively.
Calculate Digit Verification of CAS Registry Number 110548-07:
(8*1)+(7*1)+(6*0)+(5*5)+(4*4)+(3*8)+(2*0)+(1*7)=87
87 % 10 = 7
So 110548-07-7 is a valid CAS Registry Number.

110548-07-7SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 15, 2017

Revision Date: Aug 15, 2017

1.Identification

1.1 GHS Product identifier

Product name (R)-(+)-9,10-difluoro-2,3-dihydro-3-methyl-7-oxo-7H-pyrido[1,2,3-de][1,4]benzoxazine-6-carboxylic acid

1.2 Other means of identification

Product number -
Other names .[R]-(+)-9,10-difluoro-3-methyl-7-oxo-2,3-dihydro-7H-pyrido[1,2,3-de][1,4]benzoxazine-6-carboxylic acid

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:110548-07-7 SDS

110548-07-7Downstream Products

110548-07-7Relevant articles and documents

Asymmetric metal-free synthesis of fluoroquinolones by organocatalytic hydrogenation

Rueping, Magnus,Stoeckel, Mirjam,Sugiono, Erli,Theissmann, Thomas

experimental part, p. 6565 - 6568 (2010/10/19)

A highly enantioselective organocatalytic transfer hydrogenation enabling the synthesis of both 6-fluoro-2-methyltetrahydroquinoline and 7,8-difluoro-3-methyl-benzoxazine has been developed. These key building blocks can for the first time be synthesized using the same methodology allowing fast and efficient, metal-free access to the antibiotic fluoroquinolones flumequine and levofloxacine.

Optically active benzoxazines and bezothiazines and a process for their stereospecific preparation

-

, (2008/06/13)

Optically active 7,8-difluoro-3,4-dihydro-3--methyl-2H-[1,4]benzoxazines and 7,8-difluoro-3,4-dihydro-2--methyl-2H-[1,4]benzoxazines and the corresponding benzothiazines of formula III, where, one of the substituents R1, R2, R3 and R4 is CH2OH or -CH2Z, the remaining being hydrogen, X denotes fluoro, chloro, methyl or hydrogen, Y is oxygen or sulfur and Z is hydrogen, fluoro or protected hydroxyl are obtained as the stereochemically pure products of a stereospecific synthesis using a 3,4-difluoronitrobenzene substituted with a stereochemically pure 2-(1-hydroxyisopropoxy), 2-(2--hydroxypropoxy), 2-(1-hydroxyisopropylthio) or 2-(2--hydroxypropylthio) substituent. The obtained compounds are suited for the production of optically active pyridobenzoxazines and pyridobenzothiazines, among which are useful antibacterial optically active quinolones, particularly (S)-(-)-ofloxacin.

Synthesis and antibacterial activities of optically active ofloxacin and its fluoromethyl derivative.

Atarashi,Yokohama,Yamazaki,Sakano,Imamura,Hayakawa

, p. 1896 - 1902 (2007/10/02)

-

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 110548-07-7